DE69333585D1 - Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung - Google Patents

Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung

Info

Publication number
DE69333585D1
DE69333585D1 DE69333585T DE69333585T DE69333585D1 DE 69333585 D1 DE69333585 D1 DE 69333585D1 DE 69333585 T DE69333585 T DE 69333585T DE 69333585 T DE69333585 T DE 69333585T DE 69333585 D1 DE69333585 D1 DE 69333585D1
Authority
DE
Germany
Prior art keywords
toxin
methods
helicobacter pylori
vacuolizing
cleaned
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69333585T
Other languages
English (en)
Other versions
DE69333585T2 (de
Inventor
L Cover
J Blaser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vanderbilt University
Original Assignee
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanderbilt University filed Critical Vanderbilt University
Publication of DE69333585D1 publication Critical patent/DE69333585D1/de
Application granted granted Critical
Publication of DE69333585T2 publication Critical patent/DE69333585T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
DE69333585T 1992-02-26 1993-02-24 Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung Expired - Lifetime DE69333585T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84164492A 1992-02-26 1992-02-26
US841644 1992-02-26
PCT/US1993/001558 WO1993016723A1 (en) 1992-02-26 1993-02-24 Purified vacuolating toxin from helicobacter pylori and methods to use same

Publications (2)

Publication Number Publication Date
DE69333585D1 true DE69333585D1 (de) 2004-09-16
DE69333585T2 DE69333585T2 (de) 2005-07-28

Family

ID=25285365

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333585T Expired - Lifetime DE69333585T2 (de) 1992-02-26 1993-02-24 Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung

Country Status (8)

Country Link
US (2) US6054132A (de)
EP (1) EP0629132B1 (de)
JP (3) JP3920320B2 (de)
AT (1) ATE273021T1 (de)
AU (1) AU3728293A (de)
CA (1) CA2117490C (de)
DE (1) DE69333585T2 (de)
WO (1) WO1993016723A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2117490C (en) * 1992-02-26 2009-01-06 Timothy L. Cover Purified vacuolating toxin from helicobacter pylori and methods to use same
US5859219A (en) * 1992-02-26 1999-01-12 Vanderbilt University Purified vacuolating toxin from Helicobacter pylori and methods to use same
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
US6258359B1 (en) 1993-05-19 2001-07-10 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
WO1995014093A1 (en) 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
ATE244578T1 (de) * 1993-07-27 2003-07-15 Csl Ltd Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
AUPM612494A0 (en) 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
GB2290710B (en) * 1994-06-29 1998-03-25 Reckitt & Colmann Prod Ltd Protease from helicobacter pylori for use in vaccines/therapeutic compositions
GB2303855B (en) * 1994-07-01 1998-10-28 Rican Limited Helicobacter pylori antigenic protein preparation and immunoassays
GB9422331D0 (en) * 1994-11-04 1994-12-21 Biocine Spa H. pylori fermentation process
ES2283012T3 (es) 1996-01-04 2007-10-16 Novartis Vaccines And Diagnostics, Inc. Bacterioferritina de helicobacter pylori.
CA2253942A1 (en) * 1996-05-10 1997-11-20 Biogen, Inc. Common gamma chain blocking agents
US6902903B1 (en) * 1996-12-19 2005-06-07 Chiron Corporation Helicobacter pylori diagnostics
GB9807721D0 (en) * 1998-04-08 1998-06-10 Chiron Spa Antigen
WO1999057278A2 (en) 1998-04-30 1999-11-11 Chiron S.P.A. IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI)
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
ATE439454T1 (de) * 2001-04-02 2009-08-15 Point 2 Point Genomics Ltd Analyse von polynukleotiden mittels kombinatorischer pcr
CA2458854A1 (en) * 2001-08-31 2003-03-06 Chiron Srl Helicobacter pylori vaccination
AU2003223192A1 (en) * 2002-02-19 2003-09-09 The Regents Of The University Of California Proteins for helicobacter diagnosis
WO2011005587A1 (en) * 2009-06-24 2011-01-13 University Of Dubuque Vaccine compositions and methods of use to protect against infectious disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459041A (en) * 1988-02-18 1995-10-17 Enteric Research Laboratories, Inc. Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection
US4882271A (en) * 1988-03-10 1989-11-21 Baylor College Of Medicine Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection
GB2223756A (en) * 1988-09-29 1990-04-18 Health Lab Service Board Protein purification process
AU644121B2 (en) * 1989-12-04 1993-12-02 Auspharm International Limited Rapid in vitro test for helicobacter pylori using saliva
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
US5262156A (en) * 1991-08-12 1993-11-16 Hycor Biomedical, Inc. Antigenic compositions and their use for the detection of Helicobacter pylori
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
CA2117490C (en) * 1992-02-26 2009-01-06 Timothy L. Cover Purified vacuolating toxin from helicobacter pylori and methods to use same
EP0967279B1 (de) * 1992-03-02 2008-01-02 Novartis Vaccines and Diagnostics S.r.l. Helicobacter pylori Cytotoxin verwendbar in Impfstoffe und Diagnostik
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
IT1258182B (it) * 1992-08-12 1996-02-20 Composizioni contenenti bafilomycina per l'inibizione di vacuolizzazione indotta da helicobacter pylori
US5403924A (en) * 1992-10-13 1995-04-04 Vanderbilt University Taga gene and methods for detecting predisposition to peptic ulceration

Also Published As

Publication number Publication date
CA2117490A1 (en) 1993-09-02
US6013463A (en) 2000-01-11
EP0629132A4 (de) 1997-02-26
JP2005320335A (ja) 2005-11-17
ATE273021T1 (de) 2004-08-15
WO1993016723A1 (en) 1993-09-02
CA2117490C (en) 2009-01-06
EP0629132A1 (de) 1994-12-21
AU3728293A (en) 1993-09-13
US6054132A (en) 2000-04-25
DE69333585T2 (de) 2005-07-28
JP2004043469A (ja) 2004-02-12
JP3920320B2 (ja) 2007-05-30
EP0629132B1 (de) 2004-08-11
JPH07507444A (ja) 1995-08-24

Similar Documents

Publication Publication Date Title
DE69333585D1 (de) Gereinigtes vakuolisierendes toxin aus helicobacter pylori und methoden zu dessen verwendung
DE69333110D1 (de) Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose
FI20020184A (fi) Menetelmõ RS-viruksen osoittamiseksi
NO910373D0 (no) Fremgangsmaate for behandling av underjordiske formasjonerved anvendelse av et ikke-oedeleggende fraktureringsfluid.
DK388384A (da) Monoklone antistoffer med specifitet for membran-associerede antigener, deres fremstilling og anvendelse
DK0627002T3 (da) Kloning og ekspression af humaniserede monoklonale antistoffer mod human interleukin-4
NO903944D0 (no) Fremgangsmaate for fremstilling av nye peptidase og isomerase-inhibitorer.
FR2631708B1 (fr) Dispositif permettant d'effectuer des mesures ou des interventions dans un puits, methode utilisant le dispositif et applications du dispositif
NO864159D0 (no) Fremgangsmaate og anordning for rensing av gass.
DK594586A (da) Monoclonale antistoffer, der er kryds-reaktive og kryds-beskyttende mod p. aeruginosa-serotyper
NO174844C (no) Fremgangsmåte og innretning for rensing av råsilisium.
ATE220688T1 (de) Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen
NO170792C (no) Anordning til avlufting av vaeske
DK0749481T3 (da) Humaniserede monoklonale antistoffer mod human interleukin-4
DE68921908T2 (de) Zell-assoziierte Glucosyltransferase, Antikörper dagegen und eine diese enthaltende Zusammensetzung zur Prophylaxe von Karies.
NO882695D0 (no) Pigg for undersoekelse av roerledning.
DE69434087D1 (de) ENTEROTOXINE VON SHIGELLA FLEXNERI 2a
ATE144286T1 (de) Monoklonale antikörper gegen den plasmin- antiplasmin komplex, verfahren zu ihrer herstellung sowie ihre verwendung
DE69227618D1 (de) Die verwendung des leukozyten adhäsionsmolekül-1- aus endothelzellen und antikörper dagegen in der behandlung von asthma
SU630136A1 (ru) Устройство дл ст гивани ленты
SU855196A1 (ru) Устройство дл перекрыти скважины
NO881683D0 (no) Fremgangsmaate og innretning for perforering av broennboringer under utnyttelse av differensialtrykk.
NO890123L (no) Innretning for bruk av roerledninger.
DE3763812D1 (de) Geraet zum pruefen des spaltwiderstands von roehren aus pappe.
DK479687A (da) Antistoffer mod modificeret beta2-mikroglobulin samt diagnostika og praeparater indeholdende disse

Legal Events

Date Code Title Description
8364 No opposition during term of opposition